WallStreetZenWallStreetZen

NASDAQ: OCS
Oculis Holding Ag Stock

$6.99+0.00 (+0%)
Updated Mar 27, 2023
OCS Price
$6.99
Fair Value Price
N/A
Market Cap
$114.63M
52 Week Low
$6.26
52 Week High
$14.10
P/E
349.5x
P/B
-14.22x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
$342.90k
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
-1.06
Operating Cash Flow
-$515k
Beta
0.03
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

OCS Overview

European Biotech Acquisition Corp. is a "blank check" company formed to effect mergers, share exchanges, asset acquisitions, share purchases, reorganizations, or similar business combinations. It targets opportunities in the life sciences industry in Europe. European Biotech Acquisition was incorporated in 2021 and is based in Amsterdam, the Netherlands.

Zen Score

Industry Average (25)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how OCS scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

OCS was unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
OCS is poor value based on its earnings relative to its share price (349.5x), compared to the US market average (21.44x)
P/E vs Market Valuation
OCS is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 30 more OCS due diligence checks available for Premium users.

Be the first to know about important OCS news, forecast changes, insider trades & much more!

OCS News

Valuation

OCS fair value

Fair Value of OCS stock based on Discounted Cash Flow (DCF)
Price
$6.99
Fair Value
$10.77
Undervalued by
35.11%
OCS was unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

OCS price to earnings (PE)

For valuing profitable companies with steady earnings
Company
349.5x
Industry
18.55x
Market
21.44x
OCS is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
OCS is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation

OCS price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
-14.22x
Industry
4.86x

OCS's financial health

Profit margin

Revenue
$0.0
Net Income
-$968.7k
Profit Margin
0%
OCS's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$129.8M
Liabilities
$8.5M
Debt to equity
-1.06
OCS's short-term liabilities ($795.57k) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
OCS's long-term liabilities ($7.75M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
OCS's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
OCS's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$80.9k
Investing
$0.0
Financing
-$45.0k
OCS's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

OCS vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
OCS$114.63M0.00%349.50x-14.22x
MREO$115.23M0.00%-5.63x1.42x
EYEN$113.76M+5.70%-5.73x5.60x
GALT$115.88M-0.51%-3.31x-4.82x
BCTX$111.26M+3.31%-3.17x-86.89x

Oculis Holding Ag Stock FAQ

What is Oculis Holding Ag's quote symbol?

NASDAQ: OCS) Oculis Holding Ag trades on the NASDAQ under the ticker symbol OCS. Oculis Holding Ag stock quotes can also be displayed as NASDAQ: OCS.

If you're new to stock investing, here's how to buy Oculis Holding Ag stock.

What is the 52 week high and low for Oculis Holding Ag (NASDAQ: OCS)?

(NASDAQ: OCS) Oculis Holding Ag's 52-week high was $14.10, and its 52-week low was $6.26. It is currently -50.43% from its 52-week high and 11.66% from its 52-week low.

How much is Oculis Holding Ag stock worth today?

(NASDAQ: OCS) Oculis Holding Ag currently has 16,398,576 outstanding shares. With Oculis Holding Ag stock trading at $6.99 per share, the total value of Oculis Holding Ag stock (market capitalization) is $114.63M.

Oculis Holding Ag stock was originally listed at a price of $10.00 in Mar 16, 2021. If you had invested in Oculis Holding Ag stock at $10.00, your return over the last 2 years would have been -30.1%, for an annualized return of -16.39% (not including any dividends or dividend reinvestments).

How much is Oculis Holding Ag's stock price per share?

(NASDAQ: OCS) Oculis Holding Ag stock price per share is $6.99 today (as of Mar 27, 2023).

What is Oculis Holding Ag's Market Cap?

(NASDAQ: OCS) Oculis Holding Ag's market cap is $114.63M, as of Mar 29, 2023.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Oculis Holding Ag's market cap is calculated by multiplying OCS's current stock price of $6.99 by OCS's total outstanding shares of 16,398,576.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.